Primary Care to Relevant Potentially Inappropriate Medications from Beers Criteria*
Therapeutic Category/Drug | Recommendation | Therapeutic Category/Drug | Recommendation |
---|---|---|---|
Anticholinergics (Excludes TCAs) | Avoid | Barbiturates | Avoid |
Brompheniramine (oral) | Butalbital | ||
Carbinoxamine | Phenobarbital | ||
Chlorpheniramine | Benzodiazepines | Avoid for treatment of insomnia, agitation, or delirium | |
Clemastine | Short and interm. acting | ||
Cyproheptadine | Alprazolam | ||
Dexbrompheniramine | Estazolam | ||
Dexchlorpheniramine | Lorazepam | ||
Diphenhydramine | Oxazepam | ||
Doxylamine | Temazepam | ||
Hydroxyzine | Triazolam | ||
Promethazine | Long acting | ||
Triprolidine | Chlorazepate | ||
Antiparkinson agents | Chlordiazepoxide | ||
Benztropine | Avoid | Chlordiazepoxide-amitriptyline | |
Trihexyphenidyl | Clidinium-chlordiazepoxide | ||
Antispasmodics | Avoid except in short-term palliative care | Clonazepam | |
Belladonna alkaloids | Diazepam | ||
Clidinium-chlordiazepoxide | Flurazepam | ||
Dicyclomine | Quazepam | ||
Hyoscyamine | Nonbenzodiazepine hypnotics | Avoid chronic use (>90 days) | |
Propantheline | Eszopiclone | ||
Scopolamine | Zolpidem | ||
Tertiary TCAs (Alone or in Combination) | Avoid | Zaleplon | |
Amitriptyline | Megestrol | Avoid | |
Chlordiazepoxide-amitriptyline | Meprobamate | Avoid | |
Clomipramine | Trimethobenzamide | Avoid | |
Imipramine | Pain Medications | ||
Perphenazine-amitriptyline | Meperidine | Avoid | |
Trimipramine | Indomethacin | Avoid | |
Thioridazine | Avoid | Ketorolac (oral) | Avoid |
Mesoridazine | Avoid | Skeletal muscle relaxants | Avoid |
Dessicated thyroid | Avoid | Carisoprodol | |
Testosterone | Avoid unless indicated for moderate to severe hypogonadism | Chlorzoxazone | |
Cyclobenzaprine | |||
Metaxalone | |||
Estrogens with/without progestins | Avoid oral and topical patch | Methocarbamol | |
Orphenadrine | |||
Sulfonylureas, long duration | Avoid | ||
Chlorpropamide | |||
Glyburide |
TCA, tricyclic antidepressant.
↵* Primary care–relevant PIMs were selected from Table 2 of 2012 American Geriatric Society Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.24